Indivumed Therapeutics
Jonathan Woodsmith has a diverse work experience in the field of analytics and research. Jonathan started their career as a Sandwich Student at AstraZeneca in 2004. Later, they pursued a PhD at the University of Liverpool from 2007 to 2010. After that, they worked as a Postdoctoral Researcher at the Max-Planck Institute for Molecular Genetics from 2011 to 2016. Following this, they were a Postdoctoral Researcher at Karl-Franzens-Universität Graz from 2016 to 2019. Jonathan then joined Indivumed Group, where they held multiple roles such as Data Scientist, Director of Advanced Analytics, and currently serves as the VP of Advanced Analytics.
Jonathan Woodsmith earned a Bsc in Biochemistry from the University of Leeds in 2006. Jonathan then obtained a Master's degree in Molecular Biology from the University of Liverpool in 2007. Subsequently, they completed their Doctor of Philosophy (PhD) in Molecular Biology at the University of Liverpool in 2010.
Indivumed Therapeutics
1 followers
Twenty years of innovation, but a vision that remains unchanged. Valued for the standardized collection and analysis of tissue samples that has enabled a truly unique multi-omics database, we are on the verge of reshaping what is possible in the field of precision oncology. We have unlocked an understanding of the molecular reality of cancer at an unparalleled level that is now supporting biomarker and target discovery and validation, drug development, and clinical trial performance. We continue striving for a world where precision therapy is possible for each individual cancer patient. To learn more about our mission, visit www.indivumed-therapeutics.com.